Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: An ex vivo model of pig to human xenotransplantation

Transplantation

Volumn 67, Issue 1, 1999, Pages 5-18

  Baquerizo, Angeles ^a,b   Mhoyan, Anna ^c   Kearns Jonker, Mary ^d   Arnaout, Walid S ^a   Shackleton, Christopher ^a   Busuttil, Ronald W ^a,b   Demetriou, Achilles A ^a   Cramer, Donald V ^d  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c ALLEGHENY UNIVERSITY HOSPITALS   (United States)

^d Saint Vincent's Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; ARTIFICIAL LIVER; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT FAILURE; HUMAN; IMMUNE RESPONSE; LIVER CELL; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; ANTIBODY FORMATION; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, HETEROPHILE; AORTA; ENDOTHELIUM, VASCULAR; EPITOPES; EQUIPMENT DESIGN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; LIVER; LIVER FAILURE; LIVER, ARTIFICIAL; SWINE;

EID: 0033556546     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00003     Document Type: Article

References (94)

1. Bach FH. Discordant xenografting: a summary and look to the future. Transplant Proc 1992; 24: 739.
2. Markman JF, Barker CF. Basic and clinical considerations in the use of xenografts. Curr Probl Surg 1994; 31: 387.
3. Kaufman CL, Gaines BA, Ildstad ST. Xenotransplantation. Annu Rev Immunol 1995; 13: 339.
4. Cooper DKC, Ye Y, Rolf LL, Zuhdi N. The pig as potential organ donor for man. In: DKC Cooper, E Kemp, K Reemtsma, DJG White, eds. Xenotransplantation: the transplantation of organs and tissues between species. Heidelberg: Springer, 1991; 481.
5. Hammer C. Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation. Transplant Proc 1987; 19: 4443.
6. Platt JL, Bach FH. Discordant xenografting: challenges and controversies. Curr Opin Immunol 1991; 3: 735.
7. Makowka L, Cramer DV, Hoffman A, et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 1995; 59: 1654.
8. Boyden SV. Natural antibodies and the immune response. Adv Immunol 1964; 5: 1.
9. Vanhove B, Bach FH. Human xenoreactive natural antibodies: avidity and targets on porcine endothelial cells. Transplantation 1993; 56: 1251.
10. Casali P, Notkins AL. CD5+ lymphocytes, polyreactive antibodies and the human B cell repertoire. Immunol Today 1989; 10: 364.
11. Turman M-A, Casali P, Notkins L, et al. Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodies. Transplantation 1991; 52: 710.
12. Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5-B lymphocyte subset producing natural antibodies. J Immunol 1992; 148: 2690.
13. Geller RL, Bach FH, Turman MA, et al. Evidence that polyreactive antibodies are deposited in rejected discordant xenografts. Transplantation 1993; 55: 168.
14. Grabar P. Autoantibodies and the physiological role of immunoglobulins. Immunol Today 1983; 4: 337.
15. Galili U, Flechner I, Knyszynski A, et al. The natural anti-α-galactosyl IgG on human normal senescent red blood cells. Br J Haematol 1986; 62: 317.
16. McKenzie IFC, Stocker J, Ting A, Morris PA. Human lymphocytotoxic and haemagglutinating activity against sheep and pig cells. Lancet 1968; 2: 386.
17. Platt JL, Lindman BJ, Chen H, et al. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990; 50: 817.
18. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
19. Platt JL, Fischel RJ, Matas AJ, et al. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
20. Gambiez L, Salame E, Chereau C, et al. The role of natural IgM in the hyperacute rejection of discordant heart xenografts. Transplantation 1992; 54: 577.
21. Platt JL. Mechanisms of tissue injury in hyperacute xenograft rejection. ASAIO J 1992; 38: 8.
22. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238.
23. Fischel RJ, Motas AJ, Perry E, et al. Plasma exchange, organ perfusion and immunosuppression reduce "natural antibody" levels as measured by binding to xenogeneic endothelial cells and prolonged xenograft survival. Transplant Proc 1992; 24: 574.
24. Xu H, Kwiatkowski PA, Chen JM, et al. Abrogation of baboon natural xenoantibody to pig splenocytes by DL-penicillamine. Transplantation 1994; 58: 1299.
25. Kroshus TJ, Dalmasso AP, Leventhal JR, et al. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection. J Surg Res 1995; 59: 43.
26. Kroshus TJ, Bolman RM, Dalmasso AP. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 1996; 62: 5.
27. Tuso PJ, Cramer DV, Yasunaga C, et al. Removal of natural human xenoantibodies to pig vascular endothelium by perfusion of blood through pig kidneys and liver. Transplantation 1993; 55: 1375.
28. Borie DC, Cramer DV, Shirwan H, et al. Genetic control of the humoral immune response to xenografts. II. Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes. Transplantation 1995; 60: 1504.
29. Cramer DV, Wu GD. The humoral response to xenografts. Xeno 1996; 4: 30.
30. Cooke SP, Hederer RA, Pearson JD, Savage COS. Characterization of human IgG-binding xenoantigens expressed by porcine aortic endothelial cells. Transplantation 1995; 60: 1274.
31. Cotterell AH, Collins BH, Parker W, et al. The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 1995; 60: 861.
32. Satake M, Kawagishi N, Kumagai-Braesch M, et al. Specificity of human xenoantibodies formed in response to fetal porcine islet-like cell clusters. Transplant Proc 1994; 26: 1122.
33. Platt JL, Lindman BJ, Geller RL, et al. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation 1991; 52: 1037.
34. Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-α-galactosyl IgG: II. The specific recognition of α(1-3)-linked galactose residues. J Exp Med 1985; 162: 573.
35. Galili U, Buehler J, Shohet SB, Macher BA. The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by cross-reactivity between natural anti-Gal and anti-B antibodies. J Exp Med 1987; 165: 693.
36. Galili U, Shohet SB, Kobrin E, et al. Man, apes, and Old World monkeys differ form other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755.
37. Galili U, Clark MR, Shohet SB, et al. Evolutionary relationship between the natural anti-Gal antibody and the Galα1-3Gal epitope in primates. Proc Natl Acad Sci USA 1987; 84: 1369.
38. Galili U, Swanson K. Gene sequences suggest inactivation of α-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 1991; 88: 7401.
39. Good AH, Cooper DKC, Malcom AJ, et al. Identification of carbohydrate structures that bind human anti-porcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
40. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC. Antipig IgM antibodies in human serum react predominantly with Galα(1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
41. Cooper DKC, Good AH, Koren E, et al. Identification of α-galactosyl and other carbohydrates that are bound by human antipig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1993; 1: 198.
42. Oriol R, Barthod F, Bergemer Am, et al. Monomorphic and polymorphic carbohydrate antigens on pig tissues: implications for organ xenotransplantation in the pig-to-human model. Transplant Int 1994; 7: 405.
43. Collins BH, Cotterell AH, McCurry KR, et al. Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl determinant in hyperacute rejection. J Immunol 1995; 154: 5500.
44. Galili U, Rachmilweitz EA, Peleg A, Flehner I. A unique natural human IgG antibody with anti-galactosyl specificity. J Exp Med 1984; 160: 1519.
45. Hamadeh RM, Jarvis GA, Galili U, et al. Human natural antiGal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 1992; 89: 1223.
46. Rozga J, Holzman MD, Ro M, et al. Development of a hybrid bioartificial liver. Ann Surg 1993; 217: 502.
47. Watanabe FD, Mullon CJP, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure: a phase I clinical trial. Ann Surg 1997; 225: 484.
48. Vaughan HA, McKenzie IFC, Sandrin MS. Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose(α1,3)galactose reactive lectin. Transplantation 1995; 59: 102.
49. Thall A, Etienne-Decerf J, Winand R, Galili U. The α-galactosyl epitope on mammalian thyroid cells. Acta Endocrinol 1991; 124: 692.
50. Spiro RG, Bhoyroo VD. Occurrence of α-D-galactosyl residues in the thyroglobulins from several species: localization on the saccharide chains of the complex carbohydrate units. J Biol Chem 1984; 259: 9858.
51. Rydberg L, Cairns TD, Groth CG, et al. Specificities of human IgM and IgG anticarbohydrate xenoantibodies found in the sera of diabetic patients grafted with fetal pig islets. Xenotransplantation 1994; 1: 69.
52. Cooper DKC, Cairns TDH, Taube DH. Extracorporeal immunoadsorption of αGal antibodies. Xeno 1996; 4: 27.
53. Satake M, Kawagishi N, Rydberg L, et al. Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters: main antibody reactivity against α-linked galactose-containing epitopes. Xenotransplantation 1994; 1: 89.
54. Galili U, Tibell B, Samuelsson, et al. Increased anti-gal activity in diabetic patients transplanted with porcine islet cells. Transplant Proc 1996; 28: 564.
55. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for Xenotransplantation in humans. Immunol Today 1993; 14: 480.
56. Parker W, Bruno D, Holzknecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994; 153: 3791.
57. Neethling FA, Cooper DKC, Xu H, Michler RE. Newborn baboon serum anti-αgalactosyl antibody levels and cytotoxicity to cultured pig kidney (PK15) cells. Transplantation 1995; 60: 520.
58. Cairns T, Karlsson E, Holgersson J, et al Confirmation of a major target epitope of human natural IgG and IgM anti-pig antibodies: terminal galactose α1,3 galactose. Transplant Proc 1993; 26: 1384.
59. Sandrin MS, McKenzie IFC. Galα(1-3)Gal, the major xenoantigen(s) recognized in pigs by human natural antibodies. Immunol Rev 1994; 141: 169.
60. Wang L, Anaraki F, Henion TR, Galili U. Variations in activity of the human natural anti-Gal antibody in young and elderly populations. J Gerontol A Biol Sci Med Sci 1995; 50A: M227.
61. Collins BH, Parker W, Platt JL. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation 1994; 1: 36.
62. Waiter H, Guillaumin JM, Piller F, et al. Removal of terminal α-galactosyl residues from xenogeneic porcine endothelial cells: decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity. Transplantation 1996; 62: 105.
63. Galili U, Gregory CR, Morris RE. Contribution of anti-Gal to primate and human IgG binding to porcine endothelial cells. Transplantation 1995; 60: 210.
64. Golberg LC, Lee J, Cairns T, et al. Polymorphism within the human anti-pig repertoire. Transplant Proc 1996; 28: 549.
65. Platt JL, Holzknecht ZE. Porcine platelet antigens recognized by human xenoreactive natural antibodies. Transplantation 1994; 57: 327.
66. Tuso PJ, Cramer DV, Middleton YD, et al. Pig aortic endothelial cell antigens recognized by human IgM natural antibodies. Transplantation 1993; 56: 651.
67. Vetr H, Lipp J. Tumor necrosis factor-induced expression of porcine glycoproteins GP65 and GP100 recognized by human xenoreactive natural antibodies. Transplantation 1996; 62: 396.
68. Holzknecht ZE, Platt JL. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies. J Immunol 1995; 154: 4565.
69. Scherrer L, Leventhal JR, Matas AJ, Dalmasso AP. Evidence that rat xenoreactive antibodies recognize multiple protein antigens on guinea pig endothelial cells and platelets. Transplantation 1994; 58: 458.
70. Van den Bogaerde JR. Aspinall M, Wang W, et al. Induction of long-term survival of hamster heart xenografts in rats. Transplantation 1991; 52: 15.
71. Waer M, Lin Y, Vandeputte M. T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats: difference in kinetics, response to therapy and tolerization. Transplant Proc 1996; 28: 683.
72. Lin Y, Vandeputte M, Waer M. Natural killer cell-and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 1997; 158: 5658.
73. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation 1996; 62: 303.
74. Parker W, Saadi S, Lin SS, et al. Transplantation of discordant xenografts: a challenge revisited. Immunol Today 1996; 17: 373.
75. Platt JL. A perspective on xenograft rejection and accommodation. Immunol Rev 1994; 141: 127.
76. Auchincloss H Jr. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
77. Fujioka H, Cramer DV, Yasunaga C, et al. Differential patterns of reaction of human natural antibodies to pig hepatocytes and vascular endothelium. Liver Transplant Surg 1995; 1: 85
78. Li SF, Neethling FA, Taniguchi S, et al. Glycans derived from porcine stomach mucin are effective inhibitors of natural antiα-galactosyl antibodies in vitro and after intravenous infusion in baboons. Transplantation 1996; 62: 1324.
79. Taniguchi S, Neethling FA, Bovin N, et al. In vivo immunoadsorption of anti-pig antibodies in baboons using a specific αGal1-3Gal column. Transplantation 1996; 62: 1379.
80. Ravindran B, Satapathy AK, Das MK. Naturally-occurring antiα-galactosyl antibodies in human plasmodium falciparum infections: a possible role for autoantibodies in malaria. Immunol Lett 1988; 19: 137.
81. Hammarstrom L, Smith CIE. IgG subclasses in bacterial infections. Monogr Allergy 1986; 19: 122.
82. Schaapherder AFM, Daha MR, te Bulte MJW, et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57: 1376.
83. Ross JR, Kirk AD, Ibrahim SE, et al. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts: predominance of IgM and IgG2. Transplantation 1993; 55: 1144.
84. Koren E, Kujundzic M, Kosec M, et al. Cytotoxic effect of human preformed anti-Gal IgG and complement on cultured pig cells. Transplant Proc 1994; 26: 1336.
85. Goodman DJ, von Albertini M, Willson A, et al. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1996; 61: 763.
86. Miletic VD, Frank MM. Complement-immunoglobulin interactions. Curr Opin Immunol 1995, 7: 41.
87. Brewer JW, Randall TD, Parkhouse RME, Corley RB. Mechanism and subcellular localization of secretory IgM polymer assembly. J Biol Chem 1994; 269: 17338.
88. Borsos T, Rapp HJ. Complement fixation on cell surfaces by 19S and 7S antibodies. Science 1965; 150: 505.
89. Segal DM, Guyer RL, Plots PH. Complement fixation by model immune complexes free in solution and bound onto cell surfaces. Biochemistry 1979; 18: 1830.
90. Dalmasso AP, Vercellotti GM, Fischel RJ, et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
91. Miletic VD, Hester CG, Frank MM. Regulation of complement activity by immunoglobulin. J Immunol 1996; 156: 749.
92. Rice PA, Vayo HE, Tam MR, Blake MS. Immunoglobulin G antibodies directed against protein III block killing of serum resistant Neisseria gonorrhoeae by immune serum. J Exp Med 1986; 164: 1735.
93. Joiner KA, Warren KA, Brown EJ, et al. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. J Immunol 1983; 131: 1443.
94. Joiner KA, Scales R, Warren KA, et al. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J Clin Invest 1985; 76: 1765.